RCT | Simvastatin is ineffective as a disease-modifying treatment for patients with Parkinson’s Disease.

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial – JAMA Neurology

Commentary: Simvastatin Ineffective as Disease-Modifying Therapy for Intermediate Parkinson Disease – AJMC

Commentary on Twitter

In a randomized clinical trial, #simvastatin was futile as a disease-modifying therapy in UK patients with moderate #ParkinsonDisease. https://t.co/etNsG7b3fI @Pen_CTU @NIHRSW @CureParkinsonsT @UHP_NHS @PlymUni

— JAMA Neurology (@JAMANeuro) November 1, 2022